PAK1 and cancer: Pak1-/- mice are viable but exhibit immune deficiencies41 and, in genetically engineered mouse cancer models, deletion of Pak1-/- has been shown to slow tumorigenesis induced by oncogenic forms of ERBB2 or KRAS13,42.